Free shipping on all orders over $ 500

Inarigivir soproxil

Cat. No. M9530
Inarigivir soproxil Structure
Synonym:

SB 9200

Size Price Availability Quantity
10mM*1mL USD 850  USD850 In stock
10mg USD 850  USD850 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Inarigivir soproxil shows potent antiviral activity against resistant hepatitis C virus (HCV) variants, with EC50s of 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems. Inarigivir soproxil has broad-spectrum antiviral activity against RNA viruses including hepatitis C virus (HCV), norovirus, respiratory syncytial virus, and influenza and has demonstrated activity against hepatitis B virus (HBV) in vitro and in vivo.

Chemical Information
Molecular Weight 703.62
Formula C25H34N7O13PS
CAS Number 942123-43-5
Solubility (25°C) DMSO ≥ 70 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Arshad Khan, et al. Front Immunol. NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice

[2] Meleri Jones, et al. J Med Virol. SB 9200, a Novel Agonist of Innate Immunity, Shows Potent Antiviral Activity Against Resistant HCV Variants.

[3] Manasa Suresh, et al. PLoS One. Antiviral Efficacy and Host Immune Response Induction During Sequential Treatment With SB 9200 Followed by Entecavir in Woodchucks.

[4] Kyle E Korolowicz, et al. PLoS One. Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B

Related HCV Protease Products
Hepatitis C Virus S5A/5B

Hepatitis C Virus S5A/5B is a synthetic peptide substrate.

Ac-D-DGla-LI-Cha-C

Ac-D-DGla-LI-Cha-C is a potent HCV protease inhibitor peptide.

Ac-EEVVAC-pNA

Ac-EEVVAC-pNA is a chromogenic substrate for a continuous spectrophotometric assay of HCV NS3 protease.

Hepatitis Virus C NS3 Protease Inhibitor 2

Hepatitis Virus C NS3 Protease Inhibitor 2 is a product-based peptide inhibitor of hepatitis C virus (HCV) NS3 protease, with a Ki of 41 nM.

Mipomersen

Mipomersen is a 20-base gapmer (antisense oligonucleotide) that inhibits apolipoprotein B (apoB) and lowers LDL, which can be used in studies related to hyperlipidemia. In addition, Mipomersen has anti-HCV activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: Inarigivir soproxil, SB 9200 supplier, HCV Protease, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.